Cargando…
Racial Disparity in HCV Demographics and Treatment Between Interferon Era (2002–2003) and Direct Acting Anti-viral Era (2019)
Introduction Direct-acting antiviral (DAA) treatment increased the sustained viral response (SVR) rate of patients with the hepatitis C virus (HCV) and eliminated response disparities between African American (AA) and non-AA patients seen with interferon (IFN). The aim of this study was to compare...
Autores principales: | Naylor, Paul, Minawala, Ria, Wong, Katherine, Ehrinpreis, Murray N, Mutchnick, Milton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122955/ https://www.ncbi.nlm.nih.gov/pubmed/37155445 http://dx.doi.org/10.7759/cureus.36643 |
Ejemplares similares
-
Decreasing racial disparity with the combination of ledipasvir–sofosbuvir for the treatment of chronic hepatitis C
por: Naylor, Paul H, et al.
Publicado: (2017) -
Racial Disparities in Survival Outcomes of Colorectal Cancer Patients After Surgical Resection
por: Shively, Dana, et al.
Publicado: (2022) -
Trends Regarding Racial Disparities Among Malnourished Patients With Percutaneous Endoscopic Gastrostomy (PEG) Tubes
por: Khrais, Ayham, et al.
Publicado: (2022) -
Management of Ulcerative Colitis Flare-Ups in the Era of COVID-19
por: Mounsif, Sara, et al.
Publicado: (2022) -
Demographics of a large cohort of urban chronic hepatitis C patients
por: Siddiqui, Firdous A., et al.
Publicado: (2008)